Skip to content
  • Report Harm
  • Receive Newsletter
  • Press Room
Facebook Linkedin YouTube Instagram X Spotify
Benzodiazepine Information Coalition
  • About BenzodiazepinesExpand
    • Benzo BasicsExpand
      • Ashton Manual
      • A Brief History Of Benzodiazepines
      • Class Actions, Lawsuits and Reporting Harm 
      • FDA 2020 Benzodiazepine Boxed Warning
      • Medications and Supplements of Concern
      • Xanax Study Outcomes
    • PrescribingExpand
      • Addiction vs Physical Dependence
      • Genetic Testing
      • Informed Consent
      • Low Dose Benzodiazepines
      • Mechanism of Action
      • Prescribing Statistics
      • Steps to Reduce Benzodiazepine Overprescribing
      • Therapeutic Actions
    • Prescribing RisksExpand
      • Akathisia
      • Fluoroquinolones
      • Functional Brain Changes
      • Interdose Withdrawal
      • Paradoxical Reactions
      • Physical Dependence
      • Risks of Remaining on Benzodiazepines
      • Red Flags
      • Short-Term Risks
      • Side Effects
      • Suicide
      • Tolerance
    • DeprescribingExpand
      • Ashton Manual
      • Detox, Cold Turkey, Abrupt Cessation
      • Dosages Prevent Safe Withdrawal
      • Estimates of Withdrawal
      • The Maudsley Deprescribing Guidelines
      • How To Find Tapering Help
      • Phenobarbital
      • Tapering Strategies and Solutions
    • Desprescribing RisksExpand
      • Akathisia
      • Benzodiazepine Withdrawal Syndrome (BWS)
      • Forced Switching or Stopping
      • Functional Brain Changes
      • Kindling
      • Protracted Withdrawal Syndrome (PWS)
      • Suicide
      • Withdrawal & Post Withdrawal Symptoms
    • Special PopulationsExpand
      • Benzodiazepines and PTSD
      • Celebrities
      • Benzodiazepines and COVID-19
      • Older Adults
      • Women
      • Incarcerated Population
      • Substance Use Disorders
  • About UsExpand
    • Our Mission
    • Board Members and Advisors
    • Press Room
    • Receive Our Newsletter
    • FAQs
    • VolunteerExpand
      • Informed Consent Policy
      • FDA Reporting Program
      • Media Interview List Registration
  • Our ImpactExpand
    • Media Outreach
    • Press Room
    • Programs
    • Research and Publications
    • Past Speaking and Events
    • Upcoming Events
  • ResourcesExpand
    • Find Support
    • Benzodiazepine Cooperative Providers
    • Information
  • Contact Us
  • Blog
  • Donate
Donate
Facebook Linkedin X Instagram YouTube Spotify
Benzodiazepine Information Coalition

Benzodiazepine Information Coalition

Benzodiazepine Information Coalition

Educating about the potential adverse effects of benzodiazepines taken as prescribed.

ASAM Update
Research Priorities
BenzoTired Flumazenil Podcast
Renegade Psych Podcast
Support Our Mission
  • X
  • YouTube
  • Facebook
  • LinkedIn
  • Instagram
  • Spotify

Newsletter

Get notified about the latest studies, updates, calls to action, media opportunities, and more!

Support BIC

Join us in making a difference today by supporting BIC with a tax-deductible donation.

Donate

Notices

Benzodiazepine Information Coalition is a 501(c)3 tax exempt organization.

EIN: 81-3442343

Medical Disclaimer
Online Interaction Policy
Privacy Policy

Facebook Linkedin YouTube Instagram Twitter Spotify

© 2024 Benzodiazepine Information Coalition

Scroll to top
  • About Benzodiazepines
    • Benzo Basics
      • Ashton Manual
      • A Brief History Of Benzodiazepines
      • Class Actions, Lawsuits and Reporting Harm 
      • FDA 2020 Benzodiazepine Boxed Warning
      • Medications and Supplements of Concern
      • Xanax Study Outcomes
    • Prescribing
      • Addiction vs Physical Dependence
      • Genetic Testing
      • Informed Consent
      • Low Dose Benzodiazepines
      • Mechanism of Action
      • Prescribing Statistics
      • Steps to Reduce Benzodiazepine Overprescribing
      • Therapeutic Actions
    • Prescribing Risks
      • Akathisia
      • Fluoroquinolones
      • Functional Brain Changes
      • Interdose Withdrawal
      • Paradoxical Reactions
      • Physical Dependence
      • Risks of Remaining on Benzodiazepines
      • Red Flags
      • Short-Term Risks
      • Side Effects
      • Suicide
      • Tolerance
    • Deprescribing
      • Ashton Manual
      • Detox, Cold Turkey, Abrupt Cessation
      • Dosages Prevent Safe Withdrawal
      • Estimates of Withdrawal
      • The Maudsley Deprescribing Guidelines
      • How To Find Tapering Help
      • Phenobarbital
      • Tapering Strategies and Solutions
    • Desprescribing Risks
      • Akathisia
      • Benzodiazepine Withdrawal Syndrome (BWS)
      • Forced Switching or Stopping
      • Functional Brain Changes
      • Kindling
      • Protracted Withdrawal Syndrome (PWS)
      • Suicide
      • Withdrawal & Post Withdrawal Symptoms
    • Special Populations
      • Benzodiazepines and PTSD
      • Celebrities
      • Benzodiazepines and COVID-19
      • Older Adults
      • Women
      • Incarcerated Population
      • Substance Use Disorders
  • About Us
    • Our Mission
    • Board Members and Advisors
    • Press Room
    • Receive Our Newsletter
    • FAQs
    • Volunteer
      • Informed Consent Policy
      • FDA Reporting Program
      • Media Interview List Registration
  • Our Impact
    • Media Outreach
    • Press Room
    • Programs
    • Research and Publications
    • Past Speaking and Events
    • Upcoming Events
  • Resources
    • Find Support
    • Benzodiazepine Cooperative Providers
    • Information
  • Contact Us
  • Blog
  • Donate
Skip to content
Search
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset
  • ContactContact